Kenya Introduces New Prostate Cancer Screening Guidelines

The Kenyan government has introduced new guidelines for prostate cancer screening, in line with recommendations from the American Cancer Society. Men at average risk are advised to undergo a prostate-specific antigen (PSA) blood test every two years between ages 50 and 69. Those with a higher risk, including Black men and those with a close family history, are recommended to start annual PSA screening at age 45.

The Ministry of Health has identified warning signs of prostate cancer, including difficulty starting or stopping urination, frequent nighttime urination, a weak stream, and trouble emptying the bladder. However, these symptoms can also be caused by benign enlargement. As a result, many Kenyan men only seek medical attention when more severe symptoms appear, such as urinary pain, blood in urine or semen, or persistent back and pelvic pain.

According to Kenya's 2024 National Cancer Screening and Early Diagnosis Guidelines, an individualised approach to prostate cancer screening is recommended. Men are urged to discuss the benefits and risks of testing with their healthcare providers. The guidelines aim to promote early detection, but note that limited awareness and access to screening services are significant obstacles.

A study of ten sub-Saharan African countries found that the five-year relative survival rate for prostate cancer patients was around 60%. Nearly half of patients with known stage were diagnosed at an advanced stage. In contrast, survival rates exceed 99% when cancer is confined to the prostate, but drop to approximately 38% once it spreads to distant organs.

Barriers to prostate cancer screening and treatment in Kenya include limited awareness, fear of diagnosis, financial constraints, and difficulty accessing screening services. These challenges contribute to delayed treatment for many Kenyan patients. The PSA test, which measures a protein produced by the prostate, is used to detect potential cancer. Elevated levels may prompt repeat testing, imaging, or biopsy to confirm cancer.

The American Cancer Society's recommendations for prostate cancer screening are based on risk factors, including age, family history, and ethnicity. Black men and those with a close family history are considered high-risk and are advised to start screening earlier. The Kenyan government aims to promote early detection and treatment through its new guidelines.

The introduction of new prostate cancer screening guidelines in Kenya is a significant step towards improving healthcare outcomes for men. By promoting early detection and individualised screening, the government hopes to reduce the number of advanced cases and improve survival rates. Key to this effort is addressing the barriers to screening and treatment, including limited awareness and access to services.

Key points

• Kenyan men at average risk are advised to undergo PSA testing every two years between ages 50 and 69.
• The five-year relative survival rate for prostate cancer patients in sub-Saharan Africa is around 60%.
• Barriers to screening and treatment include limited awareness, fear of diagnosis, financial constraints, and difficulty accessing services.